Your browser doesn't support javascript.
loading
Asia-inclusive global development of pevonedistat: Clinical pharmacology and translational research enabling a phase 3 multiregional clinical trial.
Zhou, Xiaofei; Friedlander, Sharon; Kupperman, Erik; Sedarati, Farhad; Kuroda, Shingo; Hua, Zhaowei; Yuan, Ying; Yamamoto, Yuka; Faller, Douglas V; Haikawa, Kazue; Nakai, Katsuhiko; Bowen, Sharon; Dai, Yi; Venkatakrishnan, Karthik.
Afiliación
  • Zhou X; Millennium Pharmaceuticals, Inc. (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), Cambridge, MA, USA.
  • Friedlander S; Millennium Pharmaceuticals, Inc. (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), Cambridge, MA, USA.
  • Kupperman E; Millennium Pharmaceuticals, Inc. (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), Cambridge, MA, USA.
  • Sedarati F; Millennium Pharmaceuticals, Inc. (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), Cambridge, MA, USA.
  • Kuroda S; Takeda Pharmaceutical Company Limited, Tokyo, Japan.
  • Hua Z; Alnylam Pharmaceuticals Inc., Cambridge, MA, USA.
  • Yuan Y; Millennium Pharmaceuticals, Inc. (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), Cambridge, MA, USA.
  • Yamamoto Y; Takeda Pharmaceutical Company Limited, Tokyo, Japan.
  • Faller DV; Millennium Pharmaceuticals, Inc. (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), Cambridge, MA, USA.
  • Haikawa K; Takeda Pharmaceutical Company Limited, Tokyo, Japan.
  • Nakai K; Takeda Pharmaceutical Company Limited, Tokyo, Japan.
  • Bowen S; Millennium Pharmaceuticals, Inc. (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), Cambridge, MA, USA.
  • Dai Y; Takeda Pharmaceutical Company Limited, Beijing, China.
  • Venkatakrishnan K; Millennium Pharmaceuticals, Inc. (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), Cambridge, MA, USA.
Clin Transl Sci ; 14(3): 1069-1081, 2021 05.
Article en En | MEDLINE | ID: mdl-33503305

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacología Clínica / Pirimidinas / Protocolos de Quimioterapia Combinada Antineoplásica / Drogas en Investigación / Ciclopentanos / Investigación Biomédica Traslacional Tipo de estudio: Clinical_trials / Guideline / Incidence_studies / Prognostic_studies Límite: Humans País/Región como asunto: America do norte / Asia Idioma: En Revista: Clin Transl Sci Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacología Clínica / Pirimidinas / Protocolos de Quimioterapia Combinada Antineoplásica / Drogas en Investigación / Ciclopentanos / Investigación Biomédica Traslacional Tipo de estudio: Clinical_trials / Guideline / Incidence_studies / Prognostic_studies Límite: Humans País/Región como asunto: America do norte / Asia Idioma: En Revista: Clin Transl Sci Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos